EUVIMEDEUVIMED entdecken
Crossref

Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study

Kenji Ogata iD, Kensaku Nishihira iD, Michikazu Nakai iD, Takahiro Tokuda iD, Naoki Yoshioka iD, Akiko Tanaka iD, Shunsuke Kojima, Kohei Yamaguchi iD, Takashi Yanagiuchi iD, Tatsuro Takei iD, Tatsuya Nakama iD, Yoshisato Shibata iD und 2 weitere

Catheterization and Cardiovascular Interventions · 13.11.2026

DOI: 10.1002/ccd.71018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 13.11.2026. Verfasst von Kenji Ogata und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Second‐generation low‐dose drug‐coated balloons (LD‐DCBs) have shown clinical efficacy comparable to high‐dose DCBs (HD‐DCBs) for femoropopliteal artery (FPA) lesions. Whether paclitaxel dose density remains clinically relevant after aggressive vessel preparation with atherectomy in severely calcified FPA lesions remains uncertain. This study aimed to compare 1‐year clinical outcomes of second‐generation LD‐DCB and HD‐DCB following Jetstream atherectomy in patients with severely calcified FPA lesions.

Aims

This study aimed to compare 1‐year clinical outcomes of second‐generation LD‐DCB and HD‐DCB following Jetstream atherectomy in patients with severely calcified FPA lesions.

Methods

This multicenter retrospective study included 262 patients with severely calcified FPA lesions who underwent endovascular therapy with Jetstream atherectomy followed by second‐generation LD‐DCB ( n = 175) or HD‐DCB ( n = 87). Propensity‐score matching yielded 79 well‐balanced pairs. The primary outcome was 1‐year primary patency; secondary outcomes included freedom from clinically driven target‐lesion revascularization (TLR), limb salvage, and overall survival.

Results

In the overall cohort before matching, 1‐year primary patency was similar between second‐generation LD‐DCB and HD‐DCB (86.8% vs. 83.1%, log‐rank p = 0.578), with comparable freedom from TLR, limb salvage, and overall survival. After propensity score matching, primary patency remained similar between groups (88.5% vs. 84.9%, log‐rank p = 0.588), as did freedom from TLR, limb salvage, and overall survival. Findings were consistent across calcification‐related subgroups. In an exploratory Cox analysis, second‐generation LD‐DCB was not associated with an increased risk of restenosis compared with HD‐DCB.

Conclusions

After Jetstream atherectomy for severely calcified FPA lesions, second‐generation LD‐DCB and HD‐DCB were associated with comparable 1‐year clinical outcomes, suggesting that either strategy may be a reasonable treatment option.

Schlagwörter

Stichwörter der Autor:innen

Jetstream atherectomydrug‐coated balloonendovascular therapyfemoropopliteal artery lesionsseverely calcified

Autor:innen und Institutionen

  • Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.
  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto, Kumamoto University, Japan.
  • Department of Statistics and Data Management, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Department of Cardiology, Nagoya Heart Center, Aichi, Japan.
  • Department of Cardiology, Ogaki Municipal Hospital, Gifu, Japan.
  • Department of Cardiology, Sendai Kosei Hospital, Miyagi, Japan.

ORCID-Profile: Kenji Ogata, Kensaku Nishihira, Michikazu Nakai, Takahiro Tokuda, Naoki Yoshioka, Akiko Tanaka, Kohei Yamaguchi, Takashi Yanagiuchi, Tatsuro Takei, Tatsuya Nakama, Yoshisato Shibata, Kenichi Tsujita

Zitieren

APA

Ogata, K., Nishihira, K., Nakai, M., Tokuda, T., Yoshioka, N., Tanaka, A., Kojima, S., Yamaguchi, K., Yanagiuchi, T., Takei, T., Nakama, T., Shibata, Y., Tsujita, K., & LEADers PAD investigators (2026). Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.71018

Vancouver

Ogata K, Nishihira K, Nakai M, Tokuda T, Yoshioka N, Tanaka A, et al. Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.71018

BibTeX
@article{Ogata2026,
  author = {Ogata, Kenji and Nishihira, Kensaku and Nakai, Michikazu and Tokuda, Takahiro and Yoshioka, Naoki and Tanaka, Akiko and Kojima, Shunsuke and Yamaguchi, Kohei and Yanagiuchi, Takashi and Takei, Tatsuro and Nakama, Tatsuya and Shibata, Yoshisato and Tsujita, Kenichi and LEADers PAD investigators, LEADers PAD investigators},
  title = {Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.71018}
}
Kostenlos starten →